INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

21,218 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
MC
Maxwell Michael CaseyPresident - Western Hemisphere
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$568K
13.6K sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

Page 299 of 531
← PrevNext →
20
MC
Maxwell Michael CaseyPresident - Western Hemisphere
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL
$285K
6,782 sh
May 5, 2026
May 6, 2026
traded May 5, 2026
+1d
SEC Form 4

Evidence

20
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Open-market sale
SELL$56K
2,688 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

20
April McClain DelaneyDDependent child
SCISERVICE CORP INTERNATIONAL
Partial sale
SELL$1,001 – $15KApr 30, 2026May 6, 2026
traded Apr 30, 2026
+6dHouse PTR

Evidence

19
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
3,908 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

19
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$248K
9,030 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
4,803 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$279K
9,935 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$463K
15.9K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$271K
9,645 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$155K
5,460 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

18
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$172K
7,372 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

17
DJ
Doyle Jonathan JDirector, Hd of Financial Services Group
PIPRPIPER SANDLER COMPANIES
Open-market sale
SELL$24K
300 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

17
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$618
264 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
April McClain DelaneyDDependent child
FBINFortune Brands Innovations, Inc.
Partial sale
SELL$1,001 – $15KApr 24, 2026May 6, 2026
traded Apr 24, 2026
+12dHouse PTR

Evidence

16
April McClain DelaneyDDependent child
VIKViking Holdings Ltd
Partial sale
SELL$1,001 – $15KApr 20, 2026May 6, 2026
traded Apr 20, 2026
+16dHouse PTR

Evidence

16
April McClain DelaneyDDependent child
VIKViking Holdings Ltd
Partial sale
SELL$1,001 – $15KApr 16, 2026May 6, 2026
traded Apr 16, 2026
+20dHouse PTR

Evidence

16
April McClain DelaneyDDependent child
BROBROWN & BROWN, INC.
Partial sale
SELL$1,001 – $15KApr 17, 2026May 6, 2026
traded Apr 17, 2026
+19dHouse PTR

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$8,750
296 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
April McClain DelaneyDDependent child
MORNMorningstar, Inc.
Partial sale
SELL$1,001 – $15KApr 17, 2026May 6, 2026
traded Apr 17, 2026
+19dHouse PTR

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
683 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
700 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
2,068 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,223
312 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
2,174 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

16
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$102K
2,181 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

16
April McClain DelaneyDDependent child
MORNMorningstar, Inc.
Partial sale
SELL$1,001 – $15KApr 16, 2026May 6, 2026
traded Apr 16, 2026
+20dHouse PTR

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
8,152 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,607
325 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
8,496 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
787 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
April McClain DelaneyDDependent child
MORNMorningstar, Inc.
Partial sale
SELL$1,001 – $15KApr 30, 2026May 6, 2026
traded Apr 30, 2026
+6dHouse PTR

Evidence

16
April McClain DelaneyDDependent child
TECHBIO-TECHNE Corp
Sale
SELL$1,001 – $15KApr 8, 2026May 6, 2026
traded Apr 8, 2026
+28dHouse PTR

Evidence

14
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$75K
3,172 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

14
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$1.77M
17.4K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

13
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
311 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

13
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
968 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

13
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
310 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

13
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
931 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

12
SA
Schlachet AmirDirector, CEO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$299K
9,450 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence